- Home
- HWBK vs IPSC Comparison
HWBK vs IPSC Comparison
Compare HWBK & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HWBK | IPSC |
|---|---|---|
| Founded | 1865 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.4M | 189.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HWBK | IPSC |
|---|---|---|
| Price | $36.00 | $1.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 6.9K | ★ 3.0M |
| Earning Date | 01-28-2026 | 03-18-2026 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | ★ 31.53 | N/A |
| EPS | ★ 3.43 | N/A |
| Revenue | $79,946,000.00 | ★ $113,337,000.00 |
| Revenue This Year | N/A | $1,590.09 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.55 | ★ N/A |
| Revenue Growth | 11.22 | ★ 4122.69 |
| 52 Week Low | $25.21 | $0.34 |
| 52 Week High | $36.49 | $2.71 |
Technical Indicators
Market Signals| Indicator | HWBK | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 60.59 | 47.12 |
| Support Level | $34.66 | $1.69 |
| Resistance Level | $35.64 | $1.88 |
| Average True Range (ATR) | 0.93 | 0.29 |
| MACD | 0.41 | -0.11 |
| Stochastic Oscillator | 88.36 | 1.44 |
Price Performance
Historical ComparisonAbout HWBK Hawthorn Bancshares Inc.
Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.